Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Fluidigm Corporation stock | $6.3

Own Fluidigm Corporation stock in just a few minutes.

Fact checked

Fluidigm Corporation is a diagnostics & research business based in the US. Fluidigm Corporation shares (FLDM) are listed on the NASDAQ and all prices are listed in US Dollars. Fluidigm Corporation employs 566 staff and has a trailing 12-month revenue of around USD$126 million.

How to buy shares in Fluidigm Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Fluidigm Corporation. Find the stock by name or ticker symbol: FLDM. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fluidigm Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$6.3, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Fluidigm Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Fluidigm Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Fluidigm Corporation share price

Use our graph to track the performance of FLDM stocks over time.

Fluidigm Corporation shares at a glance

Information last updated 2020-12-26.
Latest market closeUSD$6.3
52-week rangeUSD$1.17 - USD$10.1
50-day moving average USD$6.2965
200-day moving average USD$6.4235
Wall St. target priceUSD$14.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.318

Buy Fluidigm Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Forex
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, ETFs
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Fluidigm Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Fluidigm Corporation price performance over time

Historical closes compared with the close of $6.3 from 2020-12-11

1 week (2021-01-15) 1.94%
1 month (2020-12-23) -3.52%
3 months (2020-10-22) -6.11%
6 months (2020-07-22) 5.53%
1 year (2020-01-22) 44.83%
2 years (2019-01-22) -29.69%
3 years (2018-01-22) 6.59
5 years (2016-01-22) 6.7

Is Fluidigm Corporation under- or over-valued?

Valuing Fluidigm Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fluidigm Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Fluidigm Corporation's PEG ratio

Fluidigm Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fluidigm Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Fluidigm Corporation financials

Revenue TTM USD$126 million
Gross profit TTM USD$64.3 million
Return on assets TTM -8.86%
Return on equity TTM -30.31%
Profit margin -37.85%
Book value $2.051
Market capitalisation USD$480.3 million

TTM: trailing 12 months

Shorting Fluidigm Corporation shares

There are currently 6.1 million Fluidigm Corporation shares held short by investors – that's known as Fluidigm Corporation's "short interest". This figure is 18.5% down from 7.5 million last month.

There are a few different ways that this level of interest in shorting Fluidigm Corporation shares can be evaluated.

Fluidigm Corporation's "short interest ratio" (SIR)

Fluidigm Corporation's "short interest ratio" (SIR) is the quantity of Fluidigm Corporation shares currently shorted divided by the average quantity of Fluidigm Corporation shares traded daily (recently around 1.8 million). Fluidigm Corporation's SIR currently stands at 3.44. In other words for every 100,000 Fluidigm Corporation shares traded daily on the market, roughly 3440 shares are currently held short.

However Fluidigm Corporation's short interest can also be evaluated against the total number of Fluidigm Corporation shares, or, against the total number of tradable Fluidigm Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fluidigm Corporation's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Fluidigm Corporation shares in existence, roughly 80 shares are currently held short) or 0.0839% of the tradable shares (for every 100,000 tradable Fluidigm Corporation shares, roughly 84 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Fluidigm Corporation.

Find out more about how you can short Fluidigm Corporation stock.

Fluidigm Corporation share dividends

We're not expecting Fluidigm Corporation to pay a dividend over the next 12 months.

Fluidigm Corporation share price volatility

Over the last 12 months, Fluidigm Corporation's shares have ranged in value from as little as $1.17 up to $10.1. A popular way to gauge a stock's volatility is its "beta".

FLDM.US volatility(beta: 1.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fluidigm Corporation's is 1.8929. This would suggest that Fluidigm Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Fluidigm Corporation overview

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments, consumables, and services to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. Fluidigm Corporation sells its products to academic institutions, life sciences, and clinical research laboratories that conduct research, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site